Symbols / FBLG Stock $1.10 +11.11% FibroBiologics, Inc.

Healthcare • Biotechnology • United States • NCM
FBLG (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Peter O'Heeron
Exch · Country NCM · United States
Market Cap 5.73M
Enterprise Value 2.45M
Income -18.65M
Sales —
FCF (ttm) -9.97M
Book/sh 1.85
Cash/sh 1.45
Employees 15
Insider 10d —
IPO Jan 31, 2024
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -0.29
PEG —
P/S —
P/B 0.59
P/C —
EV/EBITDA -0.15
EV/Sales —
Quick Ratio 2.78
Current Ratio 3.61
Debt/Eq 39.15
LT Debt/Eq —
EPS (ttm) -7.02
EPS next Y -3.85
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-04-30
Earnings (prior) 2026-04-30
ROA -79.85%
ROE -4.19%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 5.21M
Shs Float 2.99M
Insider Own 12.62%
Instit Own 7.18%
Short Float 2.37%
Short Ratio 0.13
Short Interest 99.97K
52W High 22.60
vs 52W High -95.13%
52W Low 0.95
vs 52W Low 15.55%
Beta 1.10
Impl. Vol. —
Rel Volume 0.60
Avg Volume 443.51K
Volume 266.67K
Target (mean) $13.50
Tgt Median $13.50
Tgt Low $8.00
Tgt High $19.00
# Analysts 2
Recom Buy
Prev Close $0.99
Price $1.10
Change 11.11%
About

FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$13.50
Mean price target
2. Current target
$1.10
Latest analyst target
3. DCF / Fair value
$-34.45
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.10
Low
$8.00
High
$19.00
Mean
$13.50

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-04 down Maxim Group Buy → Hold —
2026-04-16 main HC Wainwright & Co. Buy → Buy $8
2026-03-26 down D. Boral Capital Buy → Hold —
2026-03-12 main D. Boral Capital Buy → Buy $7
2026-02-26 main HC Wainwright & Co. Buy → Buy $4
2026-02-25 main D. Boral Capital Buy → Buy $7
2026-01-06 main D. Boral Capital Buy → Buy $15
2026-01-02 reit HC Wainwright & Co. Buy → Buy $5
2025-11-20 main D. Boral Capital Buy → Buy $15
2025-11-05 main HC Wainwright & Co. Buy → Buy $5
2025-11-03 main D. Boral Capital Buy → Buy $15
2025-09-12 reit HC Wainwright & Co. Buy → Buy $10
2025-09-10 main D. Boral Capital Buy → Buy $16
2025-08-05 main HC Wainwright & Co. Buy → Buy $12
2025-08-04 main D. Boral Capital Buy → Buy $16
2025-07-29 main D. Boral Capital Buy → Buy $16
2025-07-09 main D. Boral Capital Buy → Buy $16
2025-06-17 main D. Boral Capital Buy → Buy $16
2025-05-15 main D. Boral Capital Buy → Buy $16
2025-04-09 main D. Boral Capital Buy → Buy $16
News
RSS: Latest FBLG news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-04 O'HEERON PETER Chief Executive Officer — 51,500 $0.35 $19,531
2026-03-04 KHOJA HAMID Officer — 30,000 $0.38 $11,400
2026-03-02 DAVIS JASON D. CPA Chief Financial Officer — 70,000 $0.41 $28,973
2026-02-27 GARCIA RUBEN A General Counsel — 40,000 $0.33 $13,056
2025-12-11 GARCIA RUBEN A General Counsel — 140,000 $0.34 $47,600
2025-05-27 KHOJA HAMID Officer — 20,000 $0.84 $16,800
2024-12-09 O'HEERON PETER Chief Executive Officer — 100,000 — —
2024-12-03 O'HEERON PETER Chief Executive Officer — 50,000 — —
2024-08-12 O'HEERON PETER Chief Executive Officer — 8,500 $1.91 $16,269
2024-08-12 KHOJA HAMID Officer — 10,000 $1.90 $19,000
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
16.65
+21.20%
13.74
+54.54%
8.89
+98.99%
4.47
Research And Development
7.41
+64.45%
4.50
+90.20%
2.37
+106.45%
1.15
Selling General And Administration
9.24
+0.10%
9.23
+41.59%
6.52
+96.42%
3.32
General And Administrative Expense
9.24
+0.10%
9.23
+41.59%
6.52
+96.42%
3.32
Other Gand A
9.24
+0.10%
9.23
+41.59%
6.52
+96.42%
3.32
Total Expenses
16.65
+21.20%
13.74
+54.54%
8.89
+98.99%
4.47
Operating Income
-16.65
-21.20%
-13.74
-54.54%
-8.89
-98.99%
-4.47
Total Operating Income As Reported
-16.65
-21.20%
-13.74
-54.54%
-8.89
-98.99%
-4.47
EBITDA
-17.61
-66.64%
-10.57
+33.54%
-15.90
-263.62%
-4.37
Normalized EBITDA
-17.96
-10.26%
-16.29
-88.00%
-8.66
-98.15%
-4.37
Reconciled Depreciation
0.83
+45.20%
0.57
+31.12%
0.44
+364.89%
0.09
EBIT
-18.44
-65.53%
-11.14
+31.81%
-16.34
-265.75%
-4.47
Total Unusual Items
0.35
-93.85%
5.72
+179.08%
-7.24
—
Total Unusual Items Excluding Goodwill
0.35
-93.85%
5.72
+179.08%
-7.24
—
Net Income
-18.65
-67.06%
-11.16
+32.30%
-16.48
-221.91%
-5.12
Pretax Income
-18.65
-67.06%
-11.16
+32.30%
-16.48
-221.91%
-5.12
Net Non Operating Interest Income Expense
0.04
-81.39%
0.23
+257.14%
-0.15
+77.52%
-0.65
Interest Expense Non Operating
0.20
+920.00%
0.02
-86.39%
0.15
-77.52%
0.65
Net Interest Income
0.04
-81.39%
0.23
+257.14%
-0.15
+77.52%
-0.65
Interest Expense
0.20
+920.00%
0.02
-86.39%
0.15
-77.52%
0.65
Interest Income Non Operating
0.25
-1.59%
0.25
0.00
—
Interest Income
0.25
-1.59%
0.25
0.00
—
Other Income Expense
-2.04
-186.99%
2.35
+131.48%
-7.45
—
Other Non Operating Income Expenses
-2.39
+29.17%
-3.38
-1485.45%
-0.21
—
Gain On Sale Of Security
0.35
-93.85%
5.72
+179.08%
-7.24
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-18.65
-67.06%
-11.16
+32.30%
-16.48
-221.91%
-5.12
Net Income From Continuing Operation Net Minority Interest
-18.65
-67.06%
-11.16
+32.30%
-16.48
-221.91%
-5.12
Net Income From Continuing And Discontinued Operation
-18.65
-67.06%
-11.16
+32.30%
-16.48
-221.91%
-5.12
Net Income Continuous Operations
-18.65
-67.06%
-11.16
+32.30%
-16.48
-221.91%
-5.12
Normalized Income
-19.00
-12.53%
-16.88
-82.54%
-9.25
-80.61%
-5.12
Net Income Common Stockholders
-18.65
-67.06%
-11.16
+41.44%
-19.06
-272.15%
-5.12
Otherunder Preferred Stock Dividend
—
0.00
-100.00%
2.57
0.00
Diluted EPS
-8.40
-23.53%
-6.80
+42.06%
-11.74
-272.15%
-3.15
Basic EPS
-8.40
-23.53%
-6.80
+42.06%
-11.74
-272.15%
-3.15
Basic Average Shares
2.23
+35.85%
1.64
+1.18%
1.62
+0.05%
1.62
Diluted Average Shares
2.23
+35.85%
1.64
+1.18%
1.62
+0.05%
1.62
Diluted NI Availto Com Stockholders
-18.65
-67.06%
-11.16
+41.44%
-19.06
-272.15%
-5.12
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
9.62
-41.51%
16.45
+39.12%
11.82
+145.05%
4.82
Current Assets
6.35
-55.38%
14.23
+54.40%
9.21
+251.05%
2.62
Cash Cash Equivalents And Short Term Investments
4.89
-65.01%
13.98
+52.62%
9.16
+304.37%
2.27
Cash And Cash Equivalents
4.89
-65.01%
13.98
+52.62%
9.16
+304.37%
2.27
Receivables
—
—
0.00
-100.00%
0.30
Loans Receivable
—
—
0.00
-100.00%
0.30
Prepaid Assets
1.46
+546.67%
0.23
+525.00%
0.04
+24.14%
0.03
Other Current Assets
—
0.02
+12.50%
0.02
-46.67%
0.03
Total Non Current Assets
3.27
+47.50%
2.22
-14.93%
2.61
+18.51%
2.20
Net PPE
3.22
+45.33%
2.22
-14.93%
2.61
+18.51%
2.20
Gross PPE
3.67
+51.59%
2.42
-8.74%
2.65
+20.65%
2.20
Accumulated Depreciation
-0.45
-119.61%
-0.20
-334.04%
-0.05
0.00
Machinery Furniture Equipment
0.09
+95.74%
0.05
+67.86%
0.03
0.00
Other Properties
3.58
+50.72%
2.37
-9.56%
2.62
+19.37%
2.20
Other Non Current Assets
0.05
—
—
—
Total Liabilities Net Minority Interest
3.46
-74.74%
13.71
+29.73%
10.57
+19.82%
8.82
Current Liabilities
1.76
-86.18%
12.73
+38.58%
9.18
+29.83%
7.07
Payables And Accrued Expenses
0.94
-64.96%
2.70
+70.16%
1.58
+109.10%
0.76
Payables
0.94
-64.96%
2.70
+70.16%
1.58
+109.10%
0.76
Accounts Payable
0.94
-64.96%
2.70
+86.77%
1.44
+90.50%
0.76
Other Payable
—
—
0.14
—
Current Debt And Capital Lease Obligation
0.71
-92.62%
9.57
+2543.37%
0.36
-93.73%
5.78
Current Debt
—
9.17
—
5.45
Other Current Borrowings
—
9.17
—
5.45
Current Capital Lease Obligation
0.71
+76.06%
0.40
+10.77%
0.36
+11.04%
0.33
Other Current Liabilities
0.11
-76.52%
0.46
-93.64%
7.24
+1244.98%
0.54
Total Non Current Liabilities Net Minority Interest
1.70
+73.17%
0.98
-28.95%
1.39
-20.72%
1.75
Long Term Debt And Capital Lease Obligation
1.70
+73.17%
0.98
-28.95%
1.39
-20.72%
1.75
Long Term Capital Lease Obligation
1.70
+73.17%
0.98
-28.95%
1.39
-20.72%
1.75
Other Non Current Liabilities
—
—
0.00
—
Stockholders Equity
6.16
+125.08%
2.73
+118.28%
1.25
+131.36%
-4.00
Common Stock Equity
6.16
+125.08%
2.73
+118.28%
1.25
+131.36%
-4.00
Capital Stock
0.00
0.00
-100.00%
0.00
+0.00%
0.00
Common Stock
0.00
0.00
-100.00%
0.00
+0.00%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
3.33
+89.59%
1.75
+8.03%
1.62
+0.00%
1.62
Ordinary Shares Number
3.33
+89.59%
1.75
+8.03%
1.62
+0.00%
1.62
Additional Paid In Capital
60.32
+57.68%
38.25
+49.37%
25.61
+960.85%
2.41
Retained Earnings
-54.16
-52.50%
-35.52
-45.82%
-24.36
-209.41%
-7.87
Total Equity Gross Minority Interest
6.16
+125.08%
2.73
+118.28%
1.25
+131.36%
-4.00
Total Capitalization
6.16
+125.08%
2.73
+118.28%
1.25
+131.36%
-4.00
Working Capital
4.59
+205.59%
1.50
+4593.75%
0.03
+100.72%
-4.45
Invested Capital
6.16
-48.28%
11.90
+849.96%
1.25
-13.88%
1.46
Total Debt
2.41
-77.16%
10.55
+504.06%
1.75
-76.78%
7.52
Net Debt
—
—
—
3.19
Capital Lease Obligations
2.41
+74.01%
1.39
-20.72%
1.75
-15.73%
2.07
Net Tangible Assets
6.16
+125.08%
2.73
+118.28%
1.25
+131.36%
-4.00
Tangible Book Value
6.16
+125.08%
2.73
+118.28%
1.25
+131.36%
-4.00
Dueto Related Parties Current
—
0.00
-100.00%
0.14
0.00
Other Equity Interest
—
—
—
1.46
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-16.39
-37.75%
-11.90
-85.92%
-6.40
-57.43%
-4.07
Cash Flow From Continuing Operating Activities
-16.39
-37.75%
-11.90
-85.92%
-6.40
-57.43%
-4.07
Net Income From Continuing Operations
-18.65
-67.06%
-11.16
+32.30%
-16.48
-221.91%
-5.12
Depreciation Amortization Depletion
0.83
+45.20%
0.57
+31.12%
0.44
+364.89%
0.09
Depreciation
0.83
+45.20%
0.57
+31.12%
0.44
+364.89%
0.09
Depreciation And Amortization
0.83
+45.20%
0.57
+31.12%
0.44
+364.89%
0.09
Other Non Cash Items
—
1.86
+2200.00%
0.08
-79.18%
0.39
Stock Based Compensation
2.69
+21.05%
2.22
+25.72%
1.76
+566.04%
0.27
Operating Gains Losses
0.27
+104.77%
-5.72
-178.30%
7.31
—
Gain Loss On Investment Securities
-0.35
+93.85%
-5.72
-178.30%
7.31
—
Unrealized Gain Loss On Investment Securities
1.77
+864.22%
-0.23
0.00
—
Change In Working Capital
-3.31
-692.49%
0.56
+13.39%
0.49
+60.59%
0.31
Change In Prepaid Assets
-1.23
-550.79%
-0.19
-2600.00%
-0.01
-187.50%
0.01
Change In Payables And Accrued Expense
-1.50
-235.07%
1.11
+36.95%
0.81
+54.67%
0.53
Change In Payable
-1.50
-235.07%
1.11
+36.95%
0.81
+54.67%
0.53
Change In Account Payable
-1.50
-219.87%
1.25
+86.74%
0.67
+27.81%
0.53
Change In Other Current Assets
-0.03
-1400.00%
-0.00
-114.29%
0.01
+333.33%
-0.01
Change In Other Current Liabilities
-0.55
-51.93%
-0.36
-11.04%
-0.33
-48.18%
-0.22
Investing Cash Flow
-0.26
-42.39%
-0.18
+62.83%
-0.49
0.00
Cash Flow From Continuing Investing Activities
-0.26
-42.39%
-0.18
+62.83%
-0.49
0.00
Net PPE Purchase And Sale
-0.26
-42.39%
-0.18
+62.83%
-0.49
0.00
Purchase Of PPE
-0.26
-42.39%
-0.18
+62.83%
-0.49
0.00
Capital Expenditure
-0.26
-42.39%
-0.18
+62.83%
-0.49
—
Financing Cash Flow
7.57
-55.26%
16.91
+22.58%
13.79
+132.79%
5.92
Cash Flow From Continuing Financing Activities
7.57
-55.26%
16.91
+22.58%
13.79
+132.79%
5.92
Net Issuance Payments Of Debt
0.97
-89.63%
9.40
+3033.33%
0.30
-92.05%
3.77
Issuance Of Debt
4.38
-53.46%
9.40
+3033.33%
0.30
-93.02%
4.30
Repayment Of Debt
-3.40
0.00
0.00
+100.00%
-0.53
Short Term Debt Issuance
4.38
-53.46%
9.40
+3033.33%
0.30
-93.02%
4.30
Short Term Debt Payments
-3.40
0.00
0.00
+100.00%
-0.53
Net Short Term Debt Issuance
0.97
-89.63%
9.40
+3033.33%
0.30
-92.05%
3.77
Net Common Stock Issuance
6.59
-12.22%
7.51
0.00
—
Net Other Financing Charges
—
—
-2.65
—
Changes In Cash
-9.09
-288.53%
4.82
-30.09%
6.90
+271.01%
1.86
Beginning Cash Position
13.98
+52.62%
9.16
+304.37%
2.27
+456.76%
0.41
End Cash Position
4.89
-65.01%
13.98
+52.62%
9.16
+304.37%
2.27
Free Cash Flow
-16.66
-37.82%
-12.09
-75.25%
-6.90
-69.60%
-4.07
Interest Paid Supplemental Data
0.20
+920.00%
0.02
+900.00%
0.00
0.00
Income Tax Paid Supplemental Data
0.00
0.00
0.00
0.00
Common Stock Issuance
6.59
-12.22%
7.51
0.00
—
Issuance Of Capital Stock
6.59
-12.22%
7.51
-53.48%
16.14
+650.60%
2.15
Net Preferred Stock Issuance
—
0.00
-100.00%
16.14
+650.60%
2.15
Preferred Stock Issuance
—
0.00
-100.00%
16.14
+650.60%
2.15
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category